Skip to content

Clinical trials

Phase 2 Sarcoma, Kaposi trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma, Kaposi Phase: Phase 2 Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20051
20061
20071
20091
20112
20142
20171
20201
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)9
National Institute of Allergy and Infectious Diseases (NIAID)5
AIDS Malignancy Consortium4
Agouron Pharmaceuticals1
Baker Norton Pharmaceuticals1
Clinical Solutions1
Dana-Farber Cancer Institute1
Eastern Cooperative Oncology Group1
Hoffmann-La Roche1
ImmunityBio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma, Kaposi35
Acquired Immunodeficiency Syndrome14
HIV Infections14
Sarcoma10
Skin Neoplasms3
Chondrosarcoma2
Neoplasms2
Neuroectodermal Tumors, Primitive, Peripheral2
Osteosarcoma2
Ovarian Neoplasms2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.